CONCLUSION

Malaysia needs to push its agenda of precision medicine forward to be continuously highly rated among the healthcare systems globally. Its application will result in better and earlier diagnosis, as well as improved outcomes of treatment. The country is already equipped with an excellent overall infrastructure in terms of laboratories, biobanks, research centres, and institutions. It is also embedded with scientific and technological capabilities required to implement the initiatives and recommendations. On top of this, having a strong precision medicine initiative will further enhance collaborative research efforts with top institutions around the world, especially by leveraging the genomic diversity of its population. Besides, establishment of relevant legislation is required in tandem with addressing and managing any issues of privacy and confidentiality. The future of precision medicine is already here, and Malaysians should not allow our Nation to be left behind. Therefore, the commitment and support by the Prime Minister and the Cabinet are much needed.